For research use only. Not for therapeutic Use.
Varlilumab (CDX-1127) is a first-in-class human IgG1 anti-CD27 monoclonal antibody. Varlilumab has an anti-tumor activity[1].
| Catalog Number | I043761 |
| CAS Number | 1393344-72-3 |
| Purity | ≥95% |
| Reference | [1]. Stephen M Ansell, et al. Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies. Blood Adv. 2020 May 12;4(9):1917-1926. |
